- Drug donanemab seen arsenic turning constituent successful dementia fight BBC
- Eli Lilly's experimental Alzheimer's cause slows disease, information show The Washington Post
- What interaction volition Alzheimer’s cause donanemab have? The Guardian
- New Alzheimer's drugs could spell 'beginning of the end' for disease Sky News
- Detailed information corroborate benefits, risks of Eli Lilly's Alzheimer's drug STAT
- View Full Coverage connected Google News